Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Macrophage plasticity and polarization: in vivo veritas

Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · see citing works

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400 · see citing works

Macrophage Diversity Enhances Tumor Progression and Metastasis

Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,178 · see citing works

The consensus molecular subtypes of colorectal cancer

Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170 · see citing works

Tumour exosome integrins determine organotropic metastasis

Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101 · see citing works

Macrophage plasticity, polarization, and function in health and disease

Shapouri‐Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S., Mardani, F., Seifi, B., Mohammadi, A., Afshari, J. T., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26429 · Cited by 4,930 · see citing works

Remodelling the extracellular matrix in development and disease

Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · see citing works

The biology and function of fibroblasts in cancer

Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366 · see citing works

A framework for advancing our understanding of cancer-associated fibroblasts

Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · cited 5× · see citing works

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170 · see citing works

The prognostic landscape of genes and infiltrating immune cells across human cancers

Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,097 · see citing works

Development of Monocytes, Macrophages, and Dendritic Cells

Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049 · see citing works

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,693 · see citing works

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681 · see citing works

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590 · see citing works

Macrophages as regulators of tumour immunity and immunotherapy

DeNardo, D. G., & Ruffell, B. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,542 · see citing works

Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis

Aceto, N., Bardia, A., Miyamoto, D. T., Collier, M. D., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,438 · see citing works

Tissue-Resident Macrophages Self-Maintain Locally throughout Adult Life with Minimal Contribution from Circulating Monocytes

Hashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311 · see citing works

Concepts of extracellular matrix remodelling in tumour progression and metastasis

Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296 · see citing works

Stromal fibroblasts in cancer initiation and progression

Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,291 · see citing works

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286 · see citing works

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity

Gordon, S. R., Maute, R. L., Dulken, B. W., Hutter, G., George, B. M., McCracken, M. N., Gupta, R., Tsai, J. M., Sinha, R., Corey, D., et al. (2017) · Nature · doi:10.1038/nature22396 · Cited by 2,247 · see citing works

Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts

Elyada, E., Bolisetty, M., Laise, P., Flynn, W. F., Courtois, E. T., Burkhart, R. A., Teinor, J. A., Belleau, P., Biffi, G., Lucito, M. S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0094 · Cited by 2,241 · see citing works

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer

Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100 · see citing works

Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma

Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085 · see citing works

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

Tauriello, D. V. F., Palomo-Ponce, S., Stork, D., Berenguer-Llergo, A., Badia-Ramentol, J., Iglesias, M., Sevillano, M., Ibiza, S., Cañellas, A., Hernando-Momblona, X., et al. (2018) · Nature · doi:10.1038/nature25492 · Cited by 1,851 · see citing works

Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy

DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715 · see citing works

Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer

Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705 · cited 2× · see citing works

Phenotype molding of stromal cells in the lung tumor microenvironment

Lambrechts, D., Wauters, E., Boeckx, B., Aibar, S., Nittner, D., Burton, O., Bassez, A., Decaluwé, H., Pircher, A., Van den Eynde, K., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0096-5 · Cited by 1,648 · see citing works

Origin and functions of tissue macrophages

Epelman, S., Lavine, K. J., & Randolph, G. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.013 · Cited by 1,585 · see citing works

Neutrophils escort circulating tumour cells to enable cell cycle progression

Szczerba, B. M., Castro-Giner, F., Vetter, M. H. F., Krol, I., Gkountela, S., Landin, J., Scheidmann, M. C., Donato, C., Scherrer, R., Singer, J., et al. (2019) · Nature · doi:10.1038/s41586-019-0915-y · Cited by 1,229 · see citing works

Targeting Tumor Microenvironment for Cancer Therapy

Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040840 · Cited by 1,187 · see citing works

Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α

Kraman, M., Bambrough, P. J., Arnold, J. N., Roberts, E. W., Magiera, L., Jones, J. O., Gopinathan, A., Tuveson, D. A., & Fearon, D. T. (2010) · Science · doi:10.1126/science.1195300 · Cited by 1,134 · see citing works

Targeting STAT3 in Cancer Immunotherapy

Zou, S., Tong, Q., Liu, B., Huang, W., Tian, Y., & Fu, X. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01258-7 · Cited by 1,075 · see citing works

Stromal gene expression defines poor-prognosis subtypes in colorectal cancer

Calon, A., Lonardo, E., Berenguer-Llergo, A., Espinet, E., Hernando-Momblona, X., Iglesias, M., Sevillano, M., Palomo-Ponce, S., Tauriello, D. V. F., Byrom, D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3225 · Cited by 1,070 · see citing works

Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature

Zhang, Q., Liu, L., Gong, C., Shi, H., Zeng, Y., Wang, X., Zhao, Y., & Wei, Y.-Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050946 · Cited by 1,041 · see citing works

Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis

Zeng, Z., Li, Y., Pan, Y., Lan, X.-L., Song, F., Sun, J., Zhou, K., Liu, X., Ren, X., Wang, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07810-w · Cited by 995 · see citing works

Fibroblast heterogeneity in the cancer wound

Öhlund, D., Elyada, E., & Tuveson, D. A. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 940 · see citing works

Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer.

Kieffer, Y., Hocine, H. R., Gentric, G., Pelon, F., Bernard, C., Bourachot, B., Lameiras, S., Albergante, L., Bonneau, C., Guyard, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1384 · Cited by 910 · see citing works

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy

Liu, T., Han, C., Wang, S., Fang, P., Ma, Z., Xu, L., & Yin, R. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0770-1 · Cited by 860 · see citing works

Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy

Dominguez, C. X., Müller, S., Keerthivasan, S., Koeppen, H., Hung, J., Gierke, S., Breart, B., Foreman, O., Bainbridge, T. W., Castiglioni, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0644 · Cited by 857 · see citing works

Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo

Jetten, N., Verbruggen, S. E. L., Gijbels, M. J., Post, M. J., de Winther, M. P. J., & Donners, M. M. P. C. (2013) · Angiogenesis · doi:10.1007/s10456-013-9381-6 · Cited by 841 · see citing works

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Nywening, T. M., Wang‐Gillam, A., Sanford, D. E., Belt, B. A., Panni, R. Z., Cusworth, B. M., Toriola, A. T., Nieman, R., Worley, L. A., Yano, M., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00078-4 · Cited by 818 · see citing works

Glutamine Metabolism in Cancer: Understanding the Heterogeneity

Cluntun, A. A., Lukey, M. J., Cerione, R. A., & Locasale, J. W. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.01.005 · Cited by 796 · see citing works

Monocyte and Macrophage Plasticity in Tissue Repair and Regeneration

Das, A., Sinha, M., Datta, S., Abas, M., Chaffee, S. M., Sen, C. K., & Roy, S. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.06.001 · Cited by 747 · see citing works

Macrophages and cancer: from mechanisms to therapeutic implications

Ostuni, R., Kratochvill, F., Murray, P. J., & Natoli, G. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.004 · Cited by 685 · see citing works

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to <i>BRAF</i> Mutation and Mismatch Repair Status of the MOSAIC Study

André, T., de Gramont, A., Vernerey, D., Chibaudel, B., Bonnetain, F., Tijeras-Raballand, A., Scriva, A., Hickish, T., Tabernero, J., Van Laethem, J. L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4238 · Cited by 683 · see citing works

Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes

Winer, A., Adams, S., & Mignatti, P. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0646 · Cited by 655 · see citing works

Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors

Kumar, V., Donthireddy, L., Marvel, D., Condamine, T., Wang, F., Lavilla-Alonso, S., Hashimoto, A., Vonteddu, P., Behera, R., Goins, M. A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.005 · Cited by 653 · see citing works

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

Iliopoulos, D., Hirsch, H. A., Wang, G., & Struhl, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018898108 · Cited by 642 · see citing works

Targeting tumor‐associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

Loeffler, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26532 · Cited by 633 · see citing works

Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression

Laklai, H., Miroshnikova, Y. A., Pickup, M. W., Collisson, E. A., Kim, G., Barrett, A., Hill, R. C., Lakins, J. N., Schlaepfer, D. D., Mouw, J. K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4082 · Cited by 598 · see citing works

Malignant cells facilitate lung metastasis by bringing their own soil

Duda, D. G., Duyverman, A. M. M. J., Kohno, M., Snuderl, M., Steller, E. J. A., Fukumura, D., & Jain, R. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016234107 · Cited by 594 · see citing works

Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells

Lakins, M. A., Ghorani, E., Munir, H., Martins, C. P., & Shields, J. D. (2018) · Nature Communications · doi:10.1038/s41467-018-03347-0 · Cited by 578 · see citing works

CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer

Xu, J., Escamilla, J., Mok, S., David, J., Priceman, S. J., West, B. L., Bollag, G. E., McBride, W. H., & Wu, L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3981 · Cited by 571 · see citing works

The impact of hypoxia on tumor-associated macrophages

Henze, A.-T., & Mazzone, M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84427 · Cited by 565 · see citing works

Unraveling the therapeutic potential of the Hedgehog pathway in cancer

Amakye, D. D., Jagani, Z., & Dorsch, M. (2013) · Nature Medicine · doi:10.1038/nm.3389 · Cited by 547 · see citing works

Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression

Comito, G., Giannoni, E., Segura, C. P., Barcellos‐de‐Souza, P., Raspollini, M. R., Baroni, G., Lanciotti, M., Serni, S., & Chiarugi, P. (2013) · Oncogene · doi:10.1038/onc.2013.191 · Cited by 530 · see citing works

Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment

Teleanu, R. I., Chircov, C., Grumezescu, A. M., & Teleanu, D. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010084 · Cited by 508 · see citing works

Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells

Lo, A., Wang, L.-C. S., Scholler, J., Monslow, J., Avery, D., Newick, K., O'Brien, S., Evans, R. A., Bajor, D. J., Clendenin, C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3041 · Cited by 498 · see citing works

Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells

Yan, W., Wu, X., Zhou, W., Fong, M., Cao, M., Liu, J., Liu, X., Chen, C.-H., Fadare, O., Pizzo, D. P., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0083-6 · Cited by 466 · see citing works

Suppression of Antitumor Immunity by IL-10 and TGF-β-Producing T Cells Infiltrating the Growing Tumor: Influence of Tumor Environment on the Induction of CD4+ and CD8+ Regulatory T Cells

Jarnicki, A., Lysaght, J., Todryk, S. M., & Mills, K. H. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.896 · Cited by 446 · see citing works

Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling

Chen, W.-J., Ho, C., Chang, Y., Chen, H., Ling, T., Ling, T., Yuan, S., Yuan, S.-S., Chen, Y.-J. L., Lin, C.-Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4472 · Cited by 442 · see citing works

Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer

Cazet, A. S., Hui, M. N., Elsworth, B. L., Wu, S. Z., Roden, D., Chan, C.-L., Skhinas, J. N., Collot, R., Yang, J., Harvey, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05220-6 · Cited by 437 · see citing works

Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring

Shi, Y., Gao, W., Lytle, N. K., Huang, P., Yuan, X., Dann, A. M., Ridinger-Saison, M., DelGiorno, K. E., Antal, C. E., Liang, G., et al. (2019) · Nature · doi:10.1038/s41586-019-1130-6 · Cited by 431 · see citing works

ROCK and JAK1 Signaling Cooperate to Control Actomyosin Contractility in Tumor Cells and Stroma

Sanz-Moreno, V., Gaggioli, C., Yeo, M., Albrengues, J., Wallberg, F., Viros, A., Hooper, S., Mitter, R., Féral, C. C., Cook, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.018 · Cited by 409 · see citing works

CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells

Tsuyada, A., Chow, A., Wu, J., Somlo, G., Chu, P. G., Loera, S., Luu, T. H., Li, A. X., Wu, X., Ye, W., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3567 · Cited by 408 · see citing works

The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy

Scherz-Shouval, R., Santagata, S., Mendillo, M. L., Sholl, L. M., Ben-Aharon, I., Beck, A. H., Dias-Santagata, D., Koeva, M., Stemmer, S. M., Whitesell, L., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.045 · Cited by 386 · see citing works

Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E

Zheng, P., Luo, Q., Wang, W., Li, J., Wang, T., Wang, P., Chen, L., Zhang, P., Chen, H., Liu, Y., et al. (2018) · Cell Death &amp; Disease · doi:10.1038/s41419-018-0465-5 · Cited by 381 · see citing works

Extracellular Matrix Alterations in Metastatic Processes

Paolillo, M., & Schinelli, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194947 · Cited by 378 · see citing works

CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+T cells

Strachan, D. C., Ruffell, B., Oei, Y. A., Bissell, M. J., Coussens, L. M., Pryer, N., & Daniel, D. (2013) · OncoImmunology · doi:10.4161/onci.26968 · Cited by 376 · see citing works

Tumor macrophages are pivotal constructors of tumor collagenous matrix

Afik, R., Zigmond, E., Vugman, M., Klepfish, M., Shimshoni, E., Pasmanik‐Chor, M., Shenoy, A., Bassat, E., Halpern, Z., Geiger, T., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151193 · Cited by 376 · see citing works

Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts

Albrengues, J., Bertero, T., Grasset, E. M., Bonan, S., Maiel, M., Bourget, I., Philippe, C., Herráiz, C., Benamar, S., Croce, O., et al. (2015) · Nature Communications · doi:10.1038/ncomms10204 · Cited by 369 · see citing works

Durable antitumor responses to CD47 blockade require adaptive immune stimulation

Sockolosky, J. T., Dougan, M., Ingram, J. R., Ho, C. C. M., Kauke, M. J., Almo, S. C., Ploegh, H. L., & Garcia, K. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604268113 · Cited by 366 · see citing works

Cysteine Cathepsins and Their Extracellular Roles: Shaping the Microenvironment

Vidak, E., Javoršek, U., Vizovišek, M., & Turk, B. (2019) · Cells · doi:10.3390/cells8030264 · Cited by 365 · see citing works

Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer

Zhang, R., Qi, F., Zhao, F., Li, G., Shao, S., Zhang, X., Yuan, L., & Feng, Y. (2019) · Cell Death &amp; Disease · doi:10.1038/s41419-019-1435-2 · Cited by 343 · see citing works

Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer

Martinez‐Outschoorn, U., di Prisco, M., Ertel, A., Tsirigos, A., Lin, Z., Pavlides, S., Wang, C., Flomenberg, N., Knudsen, E. S., Howell, A., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.8.15330 · Cited by 341 · see citing works

Cancer-associated fibroblasts lead tumor invasion through integrin-β3–dependent fibronectin assembly

Atieh, Y., Clark, A. G., Graß, C., Richon, S., Pocard, M. D., Mariani, P., Elkhatib, N., Betz, T., Gurchenkov, B., & Vignjevic, D. M. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201702033 · Cited by 339 · see citing works

Transfer of miRNA in Macrophage-Derived Exosomes Induces Drug Resistance in Pancreatic Adenocarcinoma

Binenbaum, Y., Fridman, E., Yaari, Z. A., Milman, N., Schroeder, A., David, G. B., Shlomi, T., & Gil, Z. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0124 · Cited by 339 · see citing works

Targeting CCL2 with Systemic Delivery of Neutralizing Antibodies Induces Prostate Cancer Tumor Regression In vivo

Loberg, R. D., Chi, Y., Craig, M., Day, L. L., Sargent, E., Neeley, C. K., Wojno, K. J., Snyder, L. A., Li, Y., & Pienta, K. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1286 · Cited by 333 · see citing works

STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis

Heichler, C., Koop, K., Schmied, A., Geppert, C. I., Schmid, B., Wirtz, S. J., Thoma, O., Kramer, V., Waldner, M. J., Büttner, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319200 · Cited by 330 · see citing works

Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship

Netea-Maier, R. T., Smit, J. W. A., & Netea, M. G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.037 · Cited by 326 · see citing works

Cancer-associated fibroblasts induce epithelial–mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling

Goulet, C. R., Champagne, A., Bernard, G., Vandal, D., Chabaud, S., Pouliot, F., & Bolduc, S. (2019) · BMC Cancer · doi:10.1186/s12885-019-5353-6 · Cited by 322 · see citing works

The Promise of Targeting Macrophages in Cancer Therapy

Brown, J. M., Recht, L. D., & Strober, S. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3122 · Cited by 321 · see citing works

Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways

Yoshida, G. J. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01611-0 · Cited by 321 · see citing works

Exosomal Proteins as Diagnostic Biomarkers in Lung Cancer

Sandfeld‐Paulsen, B., Jakobsen, K. R., Bæk, R., Folkersen, B. H., Rasmussen, T. R., Meldgaard, P., Varming, K., Jørgensen, M. M., & Sørensen, B. S. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.034 · Cited by 311 · see citing works

Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression

Chittezhath, M., Dhillon, M. K., Lim, J. Y., Laoui, D., Shalova, I. N., Teo, Y. L., Chen, J., Kamaraj, R., Raman, L. N. M., Lum, J., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.014 · Cited by 309 · see citing works

FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells

Lee, H., Mullins, S., Franco‐Barraza, J., Valianou, M., Cukierman, E., & Cheng, J. D. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-245 · Cited by 306 · see citing works

Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma

Neuzillet, C., Tijeras‐Raballand, A., Ragulan, C., Cros, J. F., Patil, Y., Martinet, M., Erkan, M., Kleeff, J. H., Wilson, J. S., Apte, M. V., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5224 · Cited by 296 · see citing works

Cancer‐associated fibroblast and M 2 macrophage markers together predict outcome in colorectal cancer patients

Herrera, M., Herrera, A., Domínguez, G., Silva, J., García‐Barberán, V., García, J. M., Gómez, I., Soldevilla, B., Muñoz, C., Provencio, M., et al. (2013) · Cancer Science · doi:10.1111/cas.12096 · Cited by 289 · see citing works

The Carcinoma-Associated Fibroblast Expressing Fibroblast Activation Protein and Escape from Immune Surveillance

Fearon, D. T. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0002 · Cited by 288 · see citing works

Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells

Gong, J., Lin, Y., Zhang, H., Liu, C., Cheng, Z., Yang, X., Zhang, J., Xiao, Y., Jie, H., Qian, X., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2434-z · Cited by 287 · see citing works

Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma

Asgharzadeh, S., Salo, J., Ji, L., Oberthuer, A., Fischer, M., Berthold, F., Hadjidaniel, M. D., Liu, C. W.-Y., Metelitsa, L. S., Piqué-Regi, R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.9169 · Cited by 285 · see citing works

Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy

Zhou, W., Guo, S., Liu, M., Burow, M. E., & Wang, G. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170830111531 · Cited by 279 · see citing works

Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy

Caro, G. D., Cortese, N., Castino, G. F., Grizzi, F., Gavazzi, F., Ridolfi, C., Capretti, G. L., Mineri, R., Todoric, J., Zerbi, A., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309193 · Cited by 275 · see citing works

Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses

Anfray, C., Ummarino, A., Andón, F. T., & Allavena, P. (2019) · Cells · doi:10.3390/cells9010046 · Cited by 275 · see citing works

Circulating giant macrophages as a potential biomarker of solid tumors

Adams, D. L., Martin, S. S., Alpaugh, R. K., Charpentier, M. S., Tsai, S., Bergan, R. C., Ogden, I., Catàlona, W. J., Chumsri, S., Tang, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320198111 · Cited by 272 · see citing works

The Origin and Functions of Exosomes in Cancer

Rajagopal, C., & Harikumar, K. B. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00066 · Cited by 268 · see citing works

Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer

Liu, Q., Yu, Z., Yuan, S., Xie, W., Li, C., Hu, Z., Xiang, Y., Wu, N., Wu, L., Bai, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14369 · Cited by 258 · see citing works

Mechanisms of Resistance to Anti-Angiogenic Therapy and Development of Third-Generation Anti-Angiogenic Drug Candidates

Loges, S., Schmidt, T., & Carmeliet, P. (2010) · Genes & Cancer · doi:10.1177/1947601909356574 · Cited by 257 · see citing works

Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival

Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.002 · Cited by 245 · see citing works

Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts

Kong, J., Tian, H., Zhang, F., Zhang, Z., Li, J., Liu, X., Li, X., Liu, J., Li, X., Jin, D., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1101-4 · Cited by 239 · see citing works

Tumor-associated fibroblasts predominantly come from local and not circulating precursors

Arina, A., Idel, C., Hyjek, E. M., Alegre, M.-L., Wang, Y., Bindokas, V. P., Weichselbaum, R. R., & Schreiber, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600363113 · Cited by 238 · see citing works

Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer

Ao, Z., Shah, S. H., Machlin, L., Parajuli, R., Miller, P. C., Rawal, S., Williams, A. J., Côté, R. J., Lippman, M. E., Datar, R. H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1633 · Cited by 235 · see citing works

High numbers of macrophages, especially M2‐like ( CD 163‐positive), correlate with hyaluronan accumulation and poor outcome in breast cancer

Tiainen, S., Tumelius, R., Rilla, K. J., Hämäläinen, K. M., Tammi, M., Tammi, R., Kosma, V., Oikari, S., & Auvinen, P. (2014) · Histopathology · doi:10.1111/his.12607 · Cited by 234 · see citing works

Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival

Shabo, I., Stål, O., Olsson, H., Doré, S., & Svanvik, J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23527 · Cited by 225 · see citing works

Extracellular Matrix, a Hard Player in Angiogenesis

Mongiat, M., Andreuzzi, E., Tarticchio, G., & Paulitti, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111822 · Cited by 221 · see citing works

Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non–Small Cell Lung Carcinoma

Zheng, X., Weigert, A., Reu, S., Günther, S., Mansouri, S., Bassaly, B., Gattenlöhner, S., Grimminger, F., Pullamsetti, S. S., Seeger, W., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0069 · Cited by 218 · see citing works

Cancer-Stimulated CAFs Enhance Monocyte Differentiation and Protumoral TAM Activation via IL6 and GM-CSF Secretion

Cho, H., Seo, Y., Loke, K. M., Kim, S.-W., Oh, S.-M., Kim, J.-H., Soh, J., Kim, H. S., Lee, H., Kim, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0125 · Cited by 212 · see citing works

Cancer-associated fibroblasts—heroes or villains?

Gieniec, K. A., Butler, L. M., Worthley, D. L., & Woods, S. L. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0509-3 · Cited by 212 · see citing works

Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor

Patsialou, A., Wyckoff, J. B., Wang, Y., Goswami, S., Stanley, E. R., & Condeelis, J. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1868 · Cited by 207 · see citing works

Hedgehog Signaling Restrains Bladder Cancer Progression by Eliciting Stromal Production of Urothelial Differentiation Factors

Shin, K., Lim, A. Y.-L., Zhao, C., Sahoo, D., Pan, Y., Spiekerkoetter, E. F., Liao, J. C., & Beachy, P. A. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.001 · Cited by 200 · see citing works

TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts

Vallée, A., & Lecarpentier, Y. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0362-3 · Cited by 200 · see citing works

CAFs and TAMs: maestros of the tumour microenvironment

Komohara, Y., & Takeya, M. (2016) · The Journal of Pathology · doi:10.1002/path.4824 · Cited by 197 · see citing works

Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4+ and CD8+ T-Cells

Gorchs, L., Moro, C. F., Bankhead, P., Kern, K. P., Sadeak, I., Meng, Q., Rangelova, E. B., & Kaipe, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00847 · Cited by 193 · see citing works

Cancer‐associated fibroblasts and CD163‐positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance

Fujii, N., Shomori, K., Shiomi, T., Nakabayashi, M., Takeda, C., Ryoke, K., & Ito, H. (2012) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2012.01127.x · Cited by 192 · see citing works

Myeloid WNT7b Mediates the Angiogenic Switch and Metastasis in Breast Cancer

Yeo, E.-J., Cassetta, L., Qian, B., Lewkowich, I. P., Li, J., Stefater, J. A., Smith, A. N., Wiechmann, L., Wang, Y., Pollard, J. W., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2421 · Cited by 190 · see citing works

Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development

Hashimoto, O., Yoshida, M., Koma, Y., Yanai, T., Hasegawa, D., Kosaka, Y., Nishimura, N., & Yokozaki, H. (2016) · The Journal of Pathology · doi:10.1002/path.4769 · Cited by 190 · see citing works

Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors

Argyle, D. J., & Kitamura, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02629 · Cited by 190 · see citing works

Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects

Kamarudin, M. N. A., Sarker, M. M. R., Zhou, J., & Parhar, I. S. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1495-2 · Cited by 190 · see citing works

Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling

Chiang, C., Chao, T., Su, Y., Hsu, C., Chien, C., Chiu, K., Shiah, S., Lee, C.-H., Liu, S.-Y., & Shieh, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.14982 · Cited by 188 · see citing works

Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer

Tokuhisa, M., Ichikawa, Y., Kosaka, N., Ochiya, T., Yashiro, M., Hirakawa, K., Kosaka, T., Makino, H., Akiyama, H., Kunisaki, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130472 · Cited by 183 · see citing works

Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients

Macciò, A., Gramignano, G., Cherchi, M. C., Tanca, L., Melis, L., & Madeddu, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-63276-1 · Cited by 182 · see citing works

Comparative Study between Direct and Pseudomorphic Transformation of Rice Husk Ash into MFI-Type Zeolite

Alyosef, H. A., Roggendorf, H., Schneider, D., Inayat, A., Welscher, J., Schwieger, W., Münster, T., Kloess, G. H., Ibrahim, S. S., & Enke, D. (2017) · Molecules · doi:10.3390/molecules23010001 · Cited by 180 · see citing works

Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy

Tu, M. M., Abdel-Hafiz, H. A., Jones, R. T., Jean, A., Hoff, K. J., Duex, J. E., Chauca-Diaz, A., Costello, J. C., Dancik, G. M., Tamburini, B. A. J., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01441-y · Cited by 179 · see citing works

Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts

Bhagat, T. D., Ahrens, D. V., Dawlaty, M. M., Zou, Y., Baddour, J., Achreja, A., Zhao, H., Yang, L., Patel, B., Kwak, C., et al. (2019) · eLife · doi:10.7554/elife.50663 · Cited by 170 · see citing works

Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma

Lo, A., Li, C., Buza, E. L., Blomberg, R., Govindaraju, P. K., Avery, D., Monslow, J., Hsiao, M., & Puré, E. (2017) · JCI Insight · doi:10.1172/jci.insight.92232 · Cited by 160 · see citing works

Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization

Marcuzzi, E., Angioni, R., Molon, B., & Calì, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010096 · Cited by 158 · see citing works

Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site

Singh, S., Lomelino, C. L., Mboge, M. Y., Frost, S. C., & McKENNA, R. V. (2018) · Molecules · doi:10.3390/molecules23051045 · Cited by 156 · see citing works

Exosomes Derived from Human Primary and Metastatic Colorectal Cancer Cells Contribute to Functional Heterogeneity of Activated Fibroblasts by Reprogramming Their Proteome

Rai, A., Greening, D. W., Chen, M., Xu, R., Ji, H. L., & Simpson, R. J. (2018) · PROTEOMICS · doi:10.1002/pmic.201800148 · Cited by 156 · see citing works

Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer

Feng, Q., Chang, W., Mao, Y., He, G., Zheng, P., Tang, W., Wei, Y., Ren, L., Zhu, D., Ji, M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2076 · Cited by 152 · see citing works

Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma

Liu, W., Hu, J., Zhou, K., Chen, F., Wang, Z., Liao, B., Dai, Z., Cao, Y., Fan, J., & Zhou, J. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s140062 · Cited by 141 · see citing works

M2 macrophages promote NSCLC metastasis by upregulating CRYAB

Guo, Z., Song, J., Hao, J., Zhao, H., Du, X., Li, E., Kuang, Y., Yang, F., Wang, W. T., Deng, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1618-x · Cited by 140 · see citing works

Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response

Sahraei, M., Chaube, B., Liu, Y., Sun, J., Kaplan, A. R., Price, N. L., Ding, W. Y., Oyaghire, S. N., García-Milian, R., Mehta, S. S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127125 · Cited by 140 · see citing works

Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection

Zhang, H., Wang, X., Shen, Z., Xu, J., Qin, J., & Sun, Y. (2014) · Gastric Cancer · doi:10.1007/s10120-014-0422-7 · Cited by 139 · see citing works

Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types

Gandellini, P., Andriani, F., Merlino, G., D’Aiuto, F., Roz, L., & Callari, M. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.008 · Cited by 137 · see citing works

Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages

Frankenberger, C. A., Rabe, D. C., Bainer, R. O., Sankarasharma, D., Chada, K. K., Krausz, T. N., Gilad, Y., Becker, L., & Rosner, M. R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3394 · Cited by 137 · see citing works

Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth

Gerling, M., Büller, N. V. J. A., Kirn, L. M., Joost, S., Frings, O., Englert, B., Bergström, Å., Kuiper, R., Blaas, L., Wielenga, M. C. B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12321 · Cited by 129 · see citing works

Circulating microRNAs from the miR-106a–363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer

Li, M., Zhou, Y., Xia, T., Xin Min, Z. H. O. U., Huang, Z., Zhang, H., Zhu, W., Ding, Q., & Wang, S. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4757-3 · Cited by 128 · see citing works

Direct Conversion of Human Stem Cell-Derived Glial Progenitor Cells into GABAergic Interneurons

Giacomoni, J., Bruzelius, A., Stamouli, C. A., & Ottosson, D. R. (2020) · Cells · doi:10.3390/cells9112451 · Cited by 128 · see citing works

Elastin architecture

Vindin, H., Mithieux, S. M., & Weiss, A. S. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.07.005 · Cited by 126 · see citing works

Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population

Kasashima, H., Durán, Á., Martínez-Ordóñez, A., Nakanishi, Y., Kinoshita, H., Linares, J. F., Reina‐Campos, M., Kudo, Y., L’Hermitte, A., Yashiro, M., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.10.014 · Cited by 116 · see citing works

Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis

Wang, J., Yang, K., Yuan, W., & Gao, Z. (2018) · Medical Science Monitor · doi:10.12659/msm.912018 · Cited by 115 · see citing works

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers

Pelekanou, V., Villarroel‐Espíndola, F., Schalper, K. A., Pusztai, L., & Rimm, D. L. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1076-x · Cited by 109 · see citing works

Cancer-associated Fibroblasts induce epithelial-mesenchymal transition via the Transglutaminase 2-dependent IL-6/IL6R/STAT3 axis in Hepatocellular Carcinoma

Jia, C., Wang, G., Wang, T., Fu, B., Zhang, Y., Huang, L., Deng, Y., Chen, G., Wu, X., Chen, J., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45446 · Cited by 106 · see citing works

COX/mPGES-1/PGE 2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset

Larsson, K., Kock, A., Idborg, H., Arsenian‐Henriksson, M., Martinsson, T., Johnsen, J. I., Korotkova, M., Kogner, P., & Jakobsson, P. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424355112 · Cited by 105 · see citing works

Crosstalk between cancer‐associated fibroblasts and immune cells in cancer

An, Y.-Y., Liu, F., Chen, Y., & Yang, Q. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14745 · Cited by 98 · see citing works

miR-454-3p Is an Exosomal Biomarker and Functions as a Tumor Suppressor in Glioma

Shao, N., Xue, L., Wang, R., Luo, K., Zhi, F., & Lan, Q. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0725 · Cited by 96 · see citing works

Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy

Katsuya, Y., Horinouchi, H., Asao, T., Kitahara, S., Goto, Y., Kanda, S., Fujiwara, Y., Nokihara, H., Yamamoto, N., WATANABE, S.-I. I., et al. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.05.007 · Cited by 93 · see citing works

Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses

Liu, B., Guo, H., Xu, J., Qin, T. G., Guo, Q., Gu, N., Zhang, D., Qian, W., Dai, J., Hou, S., et al. (2017) · mAbs · doi:10.1080/19420862.2017.1409319 · Cited by 93 · see citing works

Cancer associated fibroblasts confer shear resistance to circulating tumor cells during prostate cancer metastatic progression

Ortiz-Otero, N., Clinch, A. B., Hope, J. M., Wang, W., Reinhart‐King, C. A., & King, M. R. (2020) · Oncotarget · doi:10.18632/oncotarget.27510 · Cited by 88 · see citing works

Biology and therapeutic targeting of tumour‐associated macrophages

Beltraminelli, T., & Palma, M. D. (2020) · The Journal of Pathology · doi:10.1002/path.5403 · Cited by 87 · see citing works

Cancer‐associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer

Aizawa, T., Karasawa, H., Funayama, R., Shirota, M., Suzuki, T., Maeda, S., Suzuki, H., Yamamura, A., Naitoh, T., Nakayama, K., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2523 · Cited by 82 · see citing works

Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site

Nasrollahzadeh, E., Razi, S., Keshavarz‐Fathi, M., Mazzone, M., & Rezaei, N. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02616-6 · Cited by 81 · see citing works

High numbers of CD163+ tumor-associated macrophages correlate with poor prognosis in multiple myeloma patients receiving bortezomib-based regimens

Wang, H., Hu, W., Xia, Z., Liang, Y., Lu, Y., Lin, S.-X., & Tang, H. (2019) · Journal of Cancer · doi:10.7150/jca.30102 · Cited by 76 · see citing works

Compartmentalized Epidermal Activation of β-Catenin Differentially Affects Lineage Reprogramming and Underlies Tumor Heterogeneity

Kretzschmar, K., Weber, C., Driskell, R. R., Calonje, E., & Watt, F. M. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.041 · Cited by 72 · see citing works

Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma

Gunderson, A. J., Yamazaki, T., McCarty, K., Phillips, M., Alice, A. F., Bambina, S., Zebertavage, L., Friedman, D. J., Cottam, B., Newell, P., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211117 · Cited by 70 · see citing works

Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors

Cancemi, P., Buttacavoli, M., Roz, E., & Feo, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163952 · Cited by 70 · see citing works

Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture

Chen, S., Giannakou, A., Wyman, S., Gruzas, J., Golas, J., Zhong, W., Loreth, C., Sridharan, L., Yamin, T.-T., Damelin, M. I., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803718115 · Cited by 67 · see citing works

Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy

Iessi, E., Logozzi, M., Mizzoni, D., Raimo, R. D., Supuran, C. T., & Fais, S. (2017) · Metabolites · doi:10.3390/metabo8010002 · Cited by 65 · see citing works

Kidney function during acute tubular necrosis: clinical studies and a theory.

Wh, M., & Rubini, M. E. (1959) · PubMed · Cited by 59 · see citing works

Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value

Ren, C.-X., Leng, R., Fan, Y., Pan, H., Li, B., Wu, C., Wu, Q., Wang, N., Xiong, Q., Geng, X., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5738 · Cited by 57 · see citing works

Treatment outcome of anti-angiogenesis through VEGF-pathway in the management of gastric cancer: a systematic review of phase II and III clinical trials

Mawalla, B. C., Yuan, X., Luo, X., & Chalya, P. L. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3137-8 · Cited by 53 · see citing works

Neutrophils: Homing in on the myeloid mechanisms of metastasis

Leach, J. D. G., Morton, J. P., & Sansom, O. J. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.12.013 · Cited by 51 · see citing works

Determinants of Resistance to Checkpoint Inhibitors

Tran, L. L., & Theodorescu, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051594 · Cited by 42 · see citing works

Macrophage Infiltration Induces Gastric Cancer Invasiveness by Activating the β-Catenin Pathway

Wu, M., Lee, W.-J., Hua, K., Kuo, M., & Lin, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134122 · Cited by 41 · see citing works

Premetastatic niches, exosomes and circulating tumor cells: Early mechanisms of tumor dissemination and the relation to surgery

Raskov, H., Orhan, A., Salanti, A., & Gögenür, I. (2019) · International Journal of Cancer · doi:10.1002/ijc.32820 · Cited by 40 · see citing works

NET silencing by let-7i in postural tachycardia syndrome

Khan, A. W., Ziemann, M., Corcoran, S. J., Kaipananickal, H., Okabe, J., Rafehi, H., Maxwell, S., Esler, M., & El‐Osta, A. (2017) · JCI Insight · doi:10.1172/jci.insight.90183 · Cited by 37 · see citing works

Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanisms

Hegab, A. E., Ozaki, M., Kagawa, S., Hamamoto, J., Yasuda, H., Naoki, K., Soejima, K., Yin, Y., Kinoshita, T., Yaguchi, T., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.02.015 · Cited by 34 · see citing works

The interaction between cancer associated fibroblasts and tumor associated macrophages via the osteopontin pathway in the tumor microenvironment of hepatocellular carcinoma

Tokuda, K., Morine, Y., Miyazaki, K., Yamada, S., Saito, Y., Nishi, M., Tokunaga, T., Ikemoto, T., Imura, S., & Shimada, M. (2021) · Oncotarget · doi:10.18632/oncotarget.27881 · Cited by 33 · see citing works

Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells

Matteo, S. D., Nevi, L., Overi, D., Landolina, N., Faccioli, J., Giulitti, F., Napoletano, C., Oddi, A., Marziani, A. M., Costantini, D., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81172-0 · Cited by 32 · see citing works

The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination

Shi, R., Chai, Y., Duan, X., Bi, X., Huang, Q., Wang, Q., Tan, S., Gao, G. F., Zhu, J., & Yan, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0121-2 · Cited by 30 · see citing works

Improvements in Progression-Free and Overall Survival Due to the Use of Anti-Angiogenic Agents in Gynecologic Cancers

Schmid, B. C., & Oehler, M. K. (2015) · Current Treatment Options in Oncology · doi:10.1007/s11864-014-0318-0 · Cited by 27 · see citing works

Production of Chemokine/Chemokine Receptor Complexes for Structural Biophysical Studies

Gustavsson, M. B., Zheng, Y., & Handel, T. M. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2015.10.003 · Cited by 27 · see citing works

Extracellular Matrix in Development and Disease

Oxford, J., Reeck, J., & Hardy, M. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010205 · Cited by 24 · see citing works

Correction: Marcuzzi, E., et al. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization. Int. J. Mol. Sci. 2019, 20, 96

Marcuzzi, E., Angioni, R., Molon, B., & Calì, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112651 · Cited by 21 · see citing works

Toll-Like Receptor 4 and Matrix Metalloproteases 11 and 13 as Predictors of Tumor Recurrence and Survival in Stage II Colorectal Cancer

Eiró, N., Carrión, J. F., Cid, S., Andicoechea, A., García-Muñiz, J. L., González, L. O., & Vizoso, F. J. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-019-00611-6 · Cited by 16 · see citing works

The Tyrosine Kinase Inhibitor Imatinib Augments Extracellular Fluid Exchange and Reduces Average Collagen Fibril Diameter in Experimental Carcinoma

Olsson, P. O., Gustafsson, R., Zandt, R. I. ‘., Friman, T., Maccarana, M., Tykesson, E., Oldberg, Å., Rubin, K., & Kalamajski, S. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0026 · Cited by 14 · see citing works

Imatinib increases oxygen delivery in extracellular matrix-rich but not in matrix-poor experimental carcinoma

Burmakin, M., van Wieringen, T., Olsson, P. O., Stuhr, L. E. B., Åhgren, A., Heldin, C., Reed, R. K., Rubin, K., & Hellberg, C. B. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1142-7 · Cited by 13 · see citing works

Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials

Hofheinz, R., Ronellenfitsch, U., Kubicka, S., Falcone, A., Burkholder, I., & Hacker, U. T. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/9189483 · Cited by 12 · see citing works

Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer

Lee, K., Park, J. W., Lee, K.-Y., Cho, S., Kwon, Y., Kim, M. J., Ryoo, S., Jeong, S., & Park, K. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-48197-y · Cited by 12 · see citing works

Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma

Honda, H., Takamura, M., Yamagiwa, S., Genda, T., Horigome, R., Kimura, N., Setsu, T., Tominaga, K., Kamimura, H., Matsuda, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15800-z · Cited by 10 · see citing works

Erratum: Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth

Gerling, M., Büller, N. V. J. A., Kirn, L. M., Joost, S., Frings, O., Englert, B., Bergström, Å., Kuiper, R., Blaas, L., Wielenga, M. C. B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12936 · Cited by 7 · see citing works

Macrophages at the interface of the co-evolving cancer ecosystem

Kloosterman, D. J., & Akkari, L. (2023) · Cell · doi:10.1016/j.cell.2023.02.020 · Cited by 436 · see citing works

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers

Zhang, H., Liu, L., Liu, J., Dang, P., Hu, S., Yuan, W., Sun, Z., Liu, Y., & Wang, C. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01725-x · Cited by 399 · see citing works

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

Lü, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Cañadas, I., Tian, Y., Niu, X., Wang, Y. Z., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 376 · see citing works

Tumor-associated macrophages: an effective player of the tumor microenvironment

Basak, U., Sarkar, T., Mukherjee, S., Chakraborty, S., Dutta, A., Dutta, S., Nayak, D., Kaushik, S., Das, T., & Sa, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1295257 · Cited by 346 · see citing works

Cancer-associated fibroblasts: The chief architect in the tumor microenvironment

Sarkar, M., Nguyen, T., Gundre, E., Ogunlusi, O., El-Sobky, M. H., Giri, B., & Sarkar, T. R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1089068 · Cited by 135 · see citing works

Recent Advances and Challenges in Cancer Immunotherapy

Peterson, C. M., Denlinger, N., & Yang, Y. (2022) · Cancers · doi:10.3390/cancers14163972 · Cited by 135 · see citing works

CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?

Zhang, C., Fei, Y., Wang, H., Hu, S., Liu, C., Hu, R., & Du, Q. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1113378 · Cited by 129 · see citing works

Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)

Mori, Y., Novruzov, E., Schmitt, D. R., Cardinale, J., Watabe, T., Choyke, P. L., Alavi, A. A., Haberkorn, U., & Giesel, F. L. (2024) · npj Imaging · doi:10.1038/s44303-024-00053-z · Cited by 122 · see citing works

Integrative Analysis From Multicenter Studies Identifies a WGCNA-Derived Cancer-Associated Fibroblast Signature for Ovarian Cancer

Feng, S., Xu, Y., Dai, Z., Yin, H., Zhang, K., & Shen, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951582 · Cited by 117 · see citing works

Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development

Samarelli, A. V., Masciale, V., Aramini, B., Coló, G. P., Tonelli, R., Marchioni, A., Bruzzi, G., Gozzi, F., Andrisani, D., Castaniere, I., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212179 · Cited by 92 · see citing works

Exosome as a Delivery Vehicle for Cancer Therapy

Moon, B., & Chang, S. (2022) · Cells · doi:10.3390/cells11030316 · Cited by 88 · see citing works

Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis

Mughees, M., Kaushal, J., Sharma, G., Wajid, S., Batra, S. K., & Siddiqui, J. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.017 · Cited by 84 · see citing works

Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers

Xu, T., Yu, S., Zhang, J., & Wu, S. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01198-9 · Cited by 78 · see citing works

Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis

Shah, S., & D’Souza, G. G. M. (2025) · Cells · doi:10.3390/cells14100732 · Cited by 66 · see citing works

Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs

Shao, S., Miao, H., & Ma, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1295684 · Cited by 66 · see citing works

Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy

Piwócka, O., Piotrowski, I., Suchorska, W. M., & Kulcenty, K. I. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1343523 · Cited by 64 · see citing works

Electroporation and Immunotherapy—Unleashing the Abscopal Effect

Justesen, T. F., Orhan, A., Raskov, H., Nolsøe, C., & Gögenür, I. (2022) · Cancers · doi:10.3390/cancers14122876 · Cited by 63 · see citing works

Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model

Ruiz-Martínez, Á., Gong, C., Wang, H., Sové, R. J., Mi, H., Kimko, H. H. C., & Popel, A. S. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010254 · Cited by 62 · see citing works

DAB2 + macrophages support FAP + fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer

Long, F., Zhong, W., Zhao, F., Xu, Y., Hu, X., Jia, G., Huang, L., Yi, K., Wang, N., Si, H., et al. (2024) · Theranostics · doi:10.7150/thno.99046 · Cited by 62 · see citing works

Hydrogels as advanced drug delivery platforms for cancer immunotherapy: promising innovations and future outlook

Mohammadzadeh, V., Atapour‐Mashhad, H., Shahvali, S., Salehi, B., Shaban, M., Shirzad, M., Salahvarzi, A., & Mohammadi, M. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03613-6 · Cited by 60 · see citing works

Artificial intelligence in digital histopathology for predicting patient prognosis and treatment efficacy in breast cancer

McCaffrey, C., Jahangir, C. A., Murphy, C. L., Burke, C., Gallagher, W. M., & Rahman, A. (2024) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2024.2346545 · Cited by 60 · see citing works

Mitochondrial Heteroplasmy Shifting as a Potential Biomarker of Cancer Progression

Pérez-Amado, C. J., Bazan-Cordoba, A., Hidalgo‐Miranda, A., & Jiménez‐Morales, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147369 · Cited by 52 · see citing works

Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway

Pradhan, R., Paul, S., Das, B., Sinha, S., Dash, S. R., Mandal, M., & Kundu, C. N. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109257 · Cited by 51 · see citing works

The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma

Ramundo, V., Zanirato, G., & Aldieri, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212216 · Cited by 46 · see citing works

Therapeutic strategies for gastric cancer targeting immune cells: Future directions

Zhao, Y. F., Bai, Y., Shen, M., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.992762 · Cited by 44 · see citing works

Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance

Popovic, A., & Tartare‐Deckert, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924553 · Cited by 42 · see citing works

Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments

Aramini, B., Masciale, V., Arienti, C., Dominici, M., Stella, F., Martinelli, G., & Fabbri, F. (2022) · Cancers · doi:10.3390/cancers14102408 · Cited by 43 · see citing works

Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis

Pradhan, R., Paul, S., Acharya, S. S., Sinha, S., Dash, S. R., & Kundu, C. N. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109568 · Cited by 42 · see citing works

Cancer-on-chip: a 3D model for the study of the tumor microenvironment

Cauli, E., Polidoro, M. A., Marzorati, S., Bernardi, C., Rasponi, M., & Lleò, A. (2023) · Journal of Biological Engineering · doi:10.1186/s13036-023-00372-6 · Cited by 41 · see citing works

Biomaterials to regulate tumor extracellular matrix in immunotherapy

Zhang, Y., Dong, X., Zhang, Y., Chen, Z., Zhou, G., Chen, N., Shen, W., Yang, K., & Pei, P. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.010 · Cited by 40 · see citing works

Metallothionein 2A Expression in Cancer-Associated Fibroblasts and Cancer Cells Promotes Esophageal Squamous Cell Carcinoma Progression

Shimizu, M., Koma, Y., Sakamoto, H., Tsukamoto, S., Kitamura, Y., Urakami, S., Tanigawa, K., Kodama, T., Higashino, N., Nishio, M., et al. (2021) · Cancers · doi:10.3390/cancers13184552 · Cited by 39 · see citing works

Regulation of cancer-associated fibroblasts for enhanced cancer immunotherapy using advanced functional nanomedicines: an updated review

Liao, T., Chen, X., Qiu, F., Zhang, X., Wu, F., Zhao, Z., Xu, M., Chen, M., Shen, J., Shen, Q., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03217-0 · Cited by 38 · see citing works

Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review

Eskandari-Malayeri, F., & Rezaei, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.996145 · Cited by 38 · see citing works

SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer

Kara, G., & Özpolat, B. (2024) · Biomedical Microdevices · doi:10.1007/s10544-024-00698-y · Cited by 36 · see citing works

The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials

Xu, C., Chen, J., Tan, M., & Tan, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1543096 · Cited by 35 · see citing works

NLRP3 activation in tumor-associated macrophages enhances lung metastasis of pancreatic ductal adenocarcinoma

Gu, H., Deng, W., Zhang, Y., Chang, Y., Shelat, V. G., Tsuchida, K., Lino-Silva, L. S., & Wang, Z. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-311 · Cited by 34 · see citing works

Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities

Han, J., Dong, L., Wu, M., & Ma, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1160340 · Cited by 35 · see citing works

Circular RNA vaccines: Pioneering the next-gen cancer immunotherapy

Das, U., Banerjee, S., Sarkar, M., Fathah Muhammad, L., Soni, T. K., Saha, M., Pradhan, G., & Chatterjee, B. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.11.003 · Cited by 32 · see citing works

Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages

Yan, Y., Yang, Y., Chen, M., Chen, J., Wang, J., Ma, Y., & Qian, H. (2021) · Biomaterials Science · doi:10.1039/d1bm01053k · Cited by 31 · see citing works

Tumor‐associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire

Malik, S., Sureka, N., Ahuja, S., Aden, D., Zaheer, S., & Zaheer, S. (2024) · Cell Biology International · doi:10.1002/cbin.12226 · Cited by 30 · see citing works

Exosomes derived from cancer-associated fibroblasts mediate response to cancer therapy

Masoudi-Khoram, N., Soheilifar, M. H., Ghorbanifar, S., Nobari, S., Hakimi, M., & Hassani, M. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.103967 · Cited by 30 · see citing works

Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines

Freitas, R., Peixoto, A., Ferreira, E., Miranda, A., Santos, L. L., & Ferreira, J. A. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108144 · Cited by 29 · see citing works

SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment

Czekay, R., Higgins, C. E., Aydin, H. B., Samarakoon, R., Subasi, N. B., Higgins, S. P., Lee, H., & Higgins, P. J. (2024) · Cells · doi:10.3390/cells13100796 · Cited by 27 · see citing works

The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies

Chen, E., Zeng, Z., & Zhou, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189198 · Cited by 29 · see citing works

Microfluidic-based human prostate-cancer-on-chip

Jiang, L., Khawaja, H., Tahsin, S., Clarkson, T. A., Miranti, C. K., & Zohar, Y. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1302223 · Cited by 26 · see citing works

GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers

Sathe, A., Ayala, C. I., Bai, X., Grimes, S. M., Lee, B., Kin, C., Shelton, A. A., Poultsides, G. A., & Ji, H. P. (2023) · Genome Medicine · doi:10.1186/s13073-023-01259-3 · Cited by 27 · see citing works

Unraveling the intricacies of cancer‐associated fibroblasts: a comprehensive review on metabolic reprogramming and tumor microenvironment crosstalk

Ahuja, S., Sureka, N., & Zaheer, S. (2024) · Apmis · doi:10.1111/apm.13447 · Cited by 25 · see citing works

Natural Compounds Targeting Cancer-Associated Fibroblasts against Digestive System Tumor Progression: Therapeutic Insights

Chiu, K.-J., Chiou, H.-Y. C., Huang, C.-H., Lu, P.-C., Kuo, H.-R., Wang, J., & Lin, M. (2022) · Biomedicines · doi:10.3390/biomedicines10030713 · Cited by 25 · see citing works

Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment

Zhang, Q., Wang, Y., & Liu, F. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110567 · Cited by 23 · see citing works

Progress in the application of hydrogels in immunotherapy of gastrointestinal tumors

Zheng, H., Li, M., Wu, L., Liu, W., Liu, Y., Gao, J., & Lu, Z. (2023) · Drug Delivery · doi:10.1080/10717544.2022.2161670 · Cited by 19 · see citing works

Tumour microenvironment and heterotypic interactions in pancreatic cancer

Velasco, R. M., García, A. G., Sánchez, P. J., Sellart, I. M., & Lobo, V. J. S.-A. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00875-8 · Cited by 18 · see citing works

Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma

Alipoor, S. D., & Chang, H. (2023) · Cells · doi:10.3390/cells12071030 · Cited by 18 · see citing works

Primary cancer-associated fibroblasts exhibit high heterogeneity among breast cancer subtypes

Piwócka, O., Musielak, M., Piotrowski, I., Kulcenty, K. I., Adamczyk, B., Fundowicz, M., Suchorska, W. M., & Malicki, J. (2023) · Reports of Practical Oncology & Radiotherapy · doi:10.5603/rpor.a2023.0026 · Cited by 17 · see citing works

Intercellular communication between FAP+ fibroblasts and SPP1+ macrophages in prostate cancer via multi-omics

Wu, T., Li, X., Zheng, F., Liu, H., & Yu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1560998 · Cited by 16 · see citing works

Targeting Cancer Through Thymoquinone: From Molecular Mechanisms to Clinical Prospects

Al-Damook, N., Sakkal, M., Khair, M., Mousa, W. K., Khoder, G., & Ghemrawi, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211029 · Cited by 15 · see citing works

Cholangiocarcinoma in the Era of Immunotherapy

Manthopoulou, E., Ramai, D., Dhar, J., Samanta, J., Ioannou, A., Lusina, E., Sacco, R., & Facciorusso, A. (2023) · Vaccines · doi:10.3390/vaccines11061062 · Cited by 15 · see citing works

Invasion and Metastasis

Schulz, W. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-16286-2_9 · Cited by 15 · see citing works

Bidirectional Regulation in the Tumour Microenvironment: The Interaction Between Tumour‐Associated Macrophages and T Cells Reshapes the Paradigm of Cancer Immunotherapy

Li, Y., & Wang, L. (2026) · Immunology · doi:10.1111/imm.70103 · Cited by 14 · see citing works

Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy

Li, K., Nie, H., Jin, R., & Wu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1397005 · Cited by 13 · see citing works

Instigation of the epoch of nanovaccines in cancer immunotherapy

Shah, S., Famta, P., Tiwari, V. K., Kotha, A. K., Kashikar, R., Chougule, M. B., Chung, Y. H., Steinmetz, N. F., Uddin, M. N., Singh, S. B., et al. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1870 · Cited by 13 · see citing works

Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis

Chen, Y., Zhang, F., Zhang, B., Trojanowicz, B., Hämmerle, M., Kleeff, J. H., & Sunami, Y. (2024) · Cancer Reports · doi:10.1002/cnr2.1990 · Cited by 12 · see citing works

miR-200-mediated inactivation of cancer-associated fibroblasts via targeting of NRP2-VEGFR signaling attenuates lung cancer invasion and metastasis

Cheon, I., Lee, S., Oh, S., & Ahn, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102194 · Cited by 12 · see citing works

Exploring the multifaceted role of direct interaction between cancer cells and fibroblasts in cancer progression

Dhungel, N., & Dragoi, A. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1379971 · Cited by 12 · see citing works

Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents

Fouillet, J., Torchio, J., Rubira, L., & Fersing, C. (2024) · Biology · doi:10.3390/biology13120967 · Cited by 12 · see citing works

Modulation of Fibroblast Activity via Vitamin D3 Is Dependent on Tumor Type—Studies on Mouse Mammary Gland Cancer

Łabędź, N., Stachowicz-Suhs, M., Psurski, M., Anisiewicz, A., Banach, J., Piotrowska, A., Dzięgiel, P., Maciejczyk, A., Matkowski, R., & Wietrzyk, J. (2022) · Cancers · doi:10.3390/cancers14194585 · Cited by 12 · see citing works

Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma

Mun, K., Han, J. W., Roh, P., Park, J. G., Kim, G., Hur, W., Jang, J. W., Choi, J., Yoon, S. K., You, Y.-K., et al. (2023) · Journal of Liver Cancer · doi:10.17998/jlc.2023.04.30 · Cited by 12 · see citing works

Immune Evasion in Head and Neck Squamous Cell Carcinoma: Roles of Cancer-Associated Fibroblasts, Immune Checkpoints, and TP53 Mutations in the Tumor Microenvironment

Tsai, C., Hsu, Y., Chu, T.-Y., Hsu, P.-C., & Kuo, C. (2025) · Cancers · doi:10.3390/cancers17152590 · Cited by 11 · see citing works

Biomedical Applications of Calcium Carbonate Nanoparticles: A Review of Recent Advances

Popova, V. K., Pyshnyi, D. V., & Dmitrienko, E. V. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00992 · Cited by 11 · see citing works

The tumor microenvironment shapes gastric cancer progression by coordinating immune suppression and metabolic reprogramming

Jiao, F., Wang, Z., Yuan, J., Shi, F., & Zhang, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1787060 · Cited by 11 · see citing works

Tumor versus Tumor Cell Targeting in Metal-Based Nanoparticles for Cancer Theranostics

Urbano‐Gámez, J. D., Guzzi, C., Bernal, M., Solivera, J., Martínez-Zubiaurre, I., Caro, C., & García‐Martín, M. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105213 · Cited by 13 · see citing works

Global research trends and focus on immunotherapy for endometrial cancer: a comprehensive bibliometric insight and visualization analysis (2012-2024)

Xu, Y., Wang, T., Liang, X., Yang, J., Zhang, Y., & Bao, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1571800 · Cited by 11 · see citing works

Decoding the CAF–TAM axis: multi-omics dissection and therapeutic targeting of stromal–immune crosstalk in the tumor microenvironment

Fu, Y., Li, M., Wu, S., Wang, J., & Wang, S. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08685-2 · Cited by 10 · see citing works

Dual effect of vitamin D3 on breast cancer-associated fibroblasts

Łabędź, N., Anisiewicz, A., Stachowicz-Suhs, M., Banach, J., Kłopotowska, D., Maciejczyk, A., Gazińska, P., Piotrowska, A., Dzięgiel, P., Matkowski, R., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-11961-z · Cited by 10 · see citing works

Morphometry and mechanical instability at the onset of epithelial bladder cancer

Lampart, F. L., Vetter, R., Yamauchi, K. A., Wang, Y., Runser, S. V. M., Strohmeyer, N., Meer, F., Hussherr, M., Camenisch, G., Seifert, H., et al. (2025) · Nature Physics · doi:10.1038/s41567-024-02735-2 · Cited by 10 · see citing works

Tracking interactions between TAMs and CAFs mediated by arginase‐induced proline production during immune evasion of HCC

Wu, C., Mao, Y., Qi, X., Wang, X., Li, P., Zhang, W., & Tang, B. (2024) · Aggregate · doi:10.1002/agt2.530 · Cited by 9 · see citing works

Tumor cell-derived osteopontin promotes tumor fibrosis indirectly via tumor-associated macrophages

Tan, Y., Yang, Y., Zhang, X., Zhao, L., Wang, X., & Liu, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06444-z · Cited by 9 · see citing works

SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer

Yu, J., Yu, S., Bai, J., Zhu, Z., Gao, Y., & Li, Y. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00758-8 · Cited by 8 · see citing works

Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation

Swetha, K. L., Maravajjala, K. S., Li, S., Singh, M. S., & Roy, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01194-7 · Cited by 8 · see citing works

Co-Culture Device for in vitro High Throughput Analysis of Cancer-Associated Fibroblast and Cancer Cell Interactions

Germain, A., & Kim, Y. T. (2023) · Oncology · doi:10.1159/000533773 · Cited by 8 · see citing works

A positive feedback loop between SERPINH1 and MMP-9/TGF-β1 promotes lung adenocarcinoma progression

Zhou, Y., Wang, X., Li, H., Fan, M., Wang, M., Gao, W., Shi, Z., Wang, J., Tan, J., & Liu, F. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01558-9 · Cited by 7 · see citing works

Cancer-associated fibroblast targeting therapies as a tool to enhance responses to radiotherapy and immunotherapy

Garate-Soraluze, E., Martínez-Zubiaurre, I., & Rodriguez-Ruiz, M. E. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009702 · Cited by 8 · see citing works

Identification of a novel reactive oxygen species (ROS)-related genes model combined with RT-qPCR experiments for prognosis and immunotherapy in gastric cancer

Cen, K., Wu, Z., Mai, Y., Dai, Y., Hong, K. M., & Guo, Y. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1074900 · Cited by 7 · see citing works

First‐in‐human study of E7130 (a tumor microenvironment‐ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose‐escalation part

Doi, T., Matsubara, N., Naito, Y., Kuboki, Y., Harano, K., Ono, M., Urasaki, T., Ohmoto, A., Kawanai, T., Hisai, T., et al. (2023) · Cancer · doi:10.1002/cncr.34788 · Cited by 7 · see citing works

Cancer-associated fibroblasts in neoadjuvant setting for solid cancers

Gu, Y., Chen, Q., Yin, H., Zeng, M., Gao, S., & Wang, X. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104226 · Cited by 7 · see citing works

The Role of Connections Between Cellular and Tissue Mechanical Elements and the Importance of Applied Energy in Mechanotransduction in Cancerous Tissue

Silver, F. H. (2025) · Biomolecules · doi:10.3390/biom15040457 · Cited by 6 · see citing works

Crosstalk between tumor-associated macrophages and the B7/CD28 family in immune checkpoint inhibitor-induced immunotherapy

Bai, R., & Sun, W. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05405-w · Cited by 7 · see citing works

The Role of Lactate Metabolism in Tumors

Tian, Z., Zhang, K., Sheng, S., Kan, C., Han, F., & Sun, X. (2025) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000001276 · Cited by 6 · see citing works

The emerging role of pancreatic exocrine fibrosis as a common aetiological driver of islet dysfunction and diabetes: opportunities for novel disease-modifying interventions

Kattner, N., Bashir, A., & Shaw, J. A. M. (2026) · Diabetologia · doi:10.1007/s00125-026-06678-6 · Cited by 6 · see citing works

Reprogramming the tumor immune microenvironment in cervical cancer: synergy between radiotherapy and immunotherapy

Wang, Z., Wang, Z., Jiang, J., Yang, L., Li, C., Deng, X., Li, Y., Yuan, J., Jiang, P., & Wang, J. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02600-1 · Cited by 6 · see citing works

Analysis of EMT induction in a non-invasive breast cancer cell line by mesenchymal stem cell supernatant: Study of 2D and 3D microfluidic based aggregate formation and migration ability, and cytoskeleton remodeling

Azadi, S., Torkashvand, E., Mohammadi, E., & Tafazzoli‐Shadpour, M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121545 · Cited by 6 · see citing works

Beyond borders: engineering organ-targeted immunotherapies to overcome site-specific barriers in cancer

Moorthy, T., Yalamandala, B. N., Huynh, T. M. H., Lien, H., Pan, W.-C., Iao, H. M., Chang, Y., & Hu, S. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01935-4 · Cited by 5 · see citing works

Multilevel classification framework for breast cancer cell selection and its integration with advanced disease models

Jones, C. F., Dias, D., Moreira, A. C., Gonçalves, G., Cinti, S., Djamgoz, M. B. A., Ferreira, F. C., Sanjuan‐Alberte, P., & Moreddu, R. (2025) · iScience · doi:10.1016/j.isci.2025.113579 · Cited by 5 · see citing works

Understanding the Dual Role of Macrophages in Tumor Growth and Therapy: A Mechanistic Review

Summer, M., Riaz, S., Ali, S., Noor, Q., Ashraf, R., & Khan, R. R. M. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402976 · Cited by 6 · see citing works

The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma

Fang, Y., Tan, C., Zheng, Z., Yang, J., Tang, J., Guo, R., Silli, E. K., Chen, Z., Chen, J., Ge, R., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116849 · Cited by 5 · see citing works

Endothelial dysfunction determines vascular mechanisms of metastatic progression in breast cancer

Mirzaeva, M., Mirzayev, A., Iriskulov, B., Бахадировна, А. С., Nizamkhodjaev, S., & Asrorov, A. M. (2026) · Discover Oncology · doi:10.1007/s12672-026-04437-y · Cited by 4 · see citing works

Leveraging selection for function in tumor evolution: System-level cancer therapies

Frédéric Thomas, A., Capp, J., Dujon, A. M., Marusyk, A., Asselin, K., Campone, M., Pujol, P., Alix‐Panabières, C., Roche, B., Újvári, B., et al. (2025) · Evolution Medicine and Public Health · doi:10.1093/emph/eoaf022 · Cited by 4 · see citing works

Pan‐cancer analysis of DCTN2 and its tumour‐promoting role in HCC by modulating the AKT pathway

Xu, S., Xing, J., Li, K., Qiao, L., Zhang, C., Ren, Y., & Liu, Y. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18450 · Cited by 4 · see citing works

Revealing molecular and cellular heterogeneity in hypopharyngeal carcinogenesis through single-cell RNA and TCR/BCR sequencing

Tie, C., Zhu, J., Yu, Z., Dou, L., Wang, M.-L., Wang, G., & Ni, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1310376 · Cited by 3 · see citing works

Targeting lipid metabolism to overcome tamoxifen resistance in breast cancer: Evaluating the synergistic therapeutic potential of quercetin

Rifaat, R. M., Kamel, M., Sharaky, M. M., Attia, Y. M., & Shouman, S. A. (2025) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2025.100953 · Cited by 3 · see citing works

Cancer-Associated Fibroblasts: Clinical Applications in Imaging and Therapy

Nilforoushan, N., Khavaran, A., Palihati, M., Patel, Y., Giarratana, A. O., Das, J. P., & Capaccione, K. M. (2025) · Tomography · doi:10.3390/tomography11120143 · Cited by 3 · see citing works

Interplay of Cancer-Associated Fibroblasts (CAFs) and Tumor-Associated Macrophages (TAMs) in Metastasis and Their Potential for Therapeutic Interventions

Sharma, I., & Sharma, A. (2023) · CRC Press eBooks · doi:10.1201/9781003220404-31

Decoding the CAF–TAM axis: multi-omics dissection and therapeutic targeting of stromal–immune crosstalk in the tumor microenvironment

Fu, Y., Li, M., Wu, S., Wang, J., & Wang, S. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08685-2 · Cited by 10 · see citing works

Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications

Huang, Z., Chen, J., Zhu, T., Li, J., Ng, H. Y., Zhou, Y., Gu, X., Xu, S., & Jia, R. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02533-1 · Cited by 46 · see citing works

Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment

Zhang, Q., Wang, Y., & Liu, F. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110567 · Cited by 23 · see citing works

CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion

Günaydın, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.668349 · Cited by 205 · see citing works